Browsing by Author "Ferrer, Marta"

Sort by: Order: Results:

  • Autoimmune diseases are linked to type IIb autoimmune chronic spontaneous urticaria
    Kolkhir, Pavel; Altrichter, Sabine; Asero, Riccardo; Daschner, Alvaro; Ferrer, Marta; Giménez Arnau, Anna Maria; Hawro, Tomasz; Jakob, Thilo; Kinaciyan, Tamar; Kromminga, Arno; Konstantinou, George N.; Makris, Michael; Metz, Martin; Skov, Per Stahl; Staubach, Petra; Sussman, Gordon; Zhang, Ke; Maurer, Marcus (Korean Academy of Asthma, Allergy and Clinical ImmunologyKorean Academy of Pediatric Allergy and Respiratory Disease, 2021)
    Purpose: Patients with chronic spontaneous urticaria (CSU) have an increased risk for comorbid autoimmune diseases. In this retrospective multicenter study of CSU patients, we evaluated clinical and laboratory features of ...
  • Efficacy and safety of on-demand versus daily rupatadine in chronic spontaneous urticaria: A randomized trial
    Weller, Karsten; Giménez Arnau, Anna Maria; Baron, Jens; Brehler, Randolf; Ferrer, Marta; Groffik, Adriane; Grundmann, Sonja; Jakob, Thilo; Labrador-Horrillo, Moisés; Müller, Sabine; Staubach, Petra; Wurpts, Gerda; Metz, Martin; Maurer, Marcus (Wiley, 2024)
    Background: Non-sedating H1 -antihistamines (nsAH) are the most commonly used treatment for chronic spontaneous urticaria (CSU). Many patients use them as on-demand (OD) therapy rather than a maintenance treatment. Here, ...
  • Predicting chronic spontaneous urticaria symptom return after omalizumab treatment discontinuation: exploratory analysis
    Ferrer, Marta; Giménez Arnau, Anna Maria; Saldana, Diego; Janssens, Nico; Balp, Maria Magdalena; Khalil, Sam; Risson, Valéry (Elsevier, 2018)
    BACKGROUND: Omalizumab is highly effective in controlling chronic spontaneous urticaria (CSU) symptoms; however, patients can experience symptom return on treatment discontinuation. Pivotal clinical trials have identified ...
  • Psychometric properties of the spanish version of the once-daily urticaria activity score (UAS) in patients with chronic spontaneous urticaria managed in clinical practice (The EVALUAS Study)
    Jauregui, Ignacio; Giménez Arnau, Anna Maria; Bartra, Joan; Labrador-Horrillo, Moisés; Ortiz de Frutos, Javier; Silvestre Salvador, Juan Francisco; Sastre, Joaquin; Velasco, Manuel; Ferrer, Marta; Ballesteros, Cristina; Valero, Antonio (BioMed Central, 2019)
    BACKGROUND: The daily diary Urticaria Activity Score (UAS) and its weekly score (UAS7) are widely used to assess signs and symptoms in patients with chronic spontaneous urticaria (CSU). The objective of this study was to ...
  • Treatment of chronic spontaneous urticaria with an inadequate response to H1-antihistamines: an expert opinion
    Vestergaard, Christian; Toubi, Elias; Maurer, Marcus; Triggiani, Massimo; Ballmer-Weber, Barbara K.; Marsland, Alexander; Ferrer, Marta; Knulst, André; Giménez Arnau, Anna Maria (John Libbey Eurotext, 2017)
    Chronic spontaneous urticaria (CSU) is characterized by the sudden, continuous or intermittent appearance of pruritic wheals (hives), angioedema, or both for six weeks or more, with no known specific trigger. The international ...
  • Unveiling chronic spontaneous urticaria pathophysiology through systems biology
    Segú-Vergés, Cristina; Gómez, Jessica; Terradas-Montana, Pau; Artigas, Laura; Smeets, Serge; Ferrer, Marta; Savic, Sinisa (Elsevier, 2023)
    Chronic spontaneous urticaria (CSU) is a rare, heterogeneous, severely debilitating, and often poorly controlled skin disease resulting in an itchy eruption that can be persistent. Antihistamines and omalizumab, an anti-IgE ...

Search DSpace

Browse

My Account

In collaboration with Compliant to Partaking